News & Events

In Singapore, OneOme and Tucker Medical Partner to Improve Preventive Care and Oncology Treatments

SINGAPORE, MINNEAPOLIS (October 11, 2017) – In Singapore, OneOme and Tucker Medical are working together to help improve preventive care and oncology treatments. OneOme is a leader in pharmacogenomic testing and Tucker Medical is a multi-specialty practice offering personalized medicine and care...


OneOme Named Finalist for 2017 Tekne Awards

Prestigious MHTA Award Recognizes Innovation and Leadership in Healthcare

MINNEAPOLIS (October 10, 2017) – Today, OneOme announced it has been named a finalist for the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards in the Healthcare category. The Tekne Awards honor Minnesota companies and individuals who have shown superior technology innovation and lea...


OneOme Participating in Individualizing Medicine Conference

Presenting Poster, Talk, Exhibit on Power of Pharmacogenomics

MINNEAPOLIS (October 9, 2017) – This week, OneOme will participate in the Individualizing Medicine 2017 Conference in Rochester, Minn. The event, which is hosted by the Mayo Clinic Center for Individualized Medicine, features experts from around the world sharing advice on the practical applicat...


OneOme Launches Upgrades to RightMed® Pharmacogenomic Solution

Adds New Gene, Psychiatry Report, Patient Report Sharing, and Insurance Billing

MINNEAPOLIS (October 5, 2017) – OneOme today launched several significant upgrades to its RightMed® pharmacogenomics solution. The RightMed solution now includes an additional gene (SLC6A4), a streamlined psychiatry report, a secure tool for patients to share their results with other providers, a...


OneOme and Rainbow Genomics Team Up to Provide Innovative Genomic Services to Patients in Hong Kong, Japan, and Macau

Partnership Combines Exome Sequencing, Pharmacogenomics Expertise

MINNEAPOLIS, HONG KONG (September 13, 2017) – Today, OneOme and Rainbow Genomics announced they are teaming up to provide genomic services to patients in Hong Kong, Japan, and Macau. OneOme’s RightMed® pharmacogenomic test will be offered alongside Rainbow Genomics’ whole exome sequencing tes...